|
Search
Collections
Benchmarks
Upload document
Product
Capozide
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Healthy Control Participants
Clinical trial
An Open-label, Randomized Three Period, Three Sequence, Partially Replicated Crossover Bioequivalence Study of Two Oral Formulations of Captopril/Hydrochlorothiazide 50/25 mg Tablets in Healthy Adult Participants Under Fasting Conditions
Status: Withdrawn
, Estimated PCD: 2022-05-26